Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01853917 · ClinicalTrials.gov registry record

Evaluation of Barriers to Postpartum Care in HIV Infected Women

A clinical trial of Pregnancy and HIV Infection, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
38
Enrollment target
2
Study locations

NCT01853917: Completed study of Pregnancy and HIV Infection, sponsored by The University of Texas Health Science Center, Houston.

NCT01853917 is a study of Pregnancy and HIV Infection that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 38 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01853917, a study of Pregnancy and HIV Infection, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
38 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate why the majority of HIV infected women in the Harris County Health District system who are pregnant do not come to clinic for their HIV disease after they have a baby through questionaires administered prepartum and questionaires and structured interviews postpartum. The study will ask subjects questions about HIV, drug use, depression and social problems.

Primary Outcome

we will ask and record responses and enter into an NIVIVO program to evaluate for emergent themes

Conditions Studied

Interventions

  • OTHER questionaires and structured interviews

Study Locations (2)

Texas

  • Harris County Hospital District Clinics-Thomas Street Clinic, Northwest Clinic - Houston
  • Harris County Hospital District Clinics-LBJ hospital - Houston

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2012-01
Est. Completion 2014-11

What the finished NCT01853917 record still lists

NCT01853917 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which questionaires and structured interviews is the first listed.

NCT01853917 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01853917 about?

NCT01853917 is a clinical study titled "Evaluation of Barriers to Postpartum Care in HIV Infected Women". The purpose of this study is to evaluate why the majority of HIV infected women in the Harris County Health District system who are pregnant do not come to clinic for their HIV disease after they have a baby through questionaires administered prepartum and questionaires and structured interviews pos...

What is the current status of trial NCT01853917?

This trial is currently completed. The enrollment target is 38 participants. The study started on 2012-01. Estimated completion is 2014-11.

What conditions does trial NCT01853917 study?

This clinical trial studies the following conditions: Pregnancy, HIV Infection.

What interventions are being tested in trial NCT01853917?

The interventions under investigation include: questionaires and structured interviews (OTHER).

Who is sponsoring clinical trial NCT01853917?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01853917 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01853917's enrollment target sits among peer trials

38 167th of 191 higher than 25 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01853917, the US trial registry maintained by the National Library of Medicine. NCT01853917 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.